ID   WA-C3CD5+
AC   CVCL_Y438
SY   WaC3 CD5+; WaC3CD5+; WaC3CD5; WAC3CD5+; WAC3-CD5; WAC-CD5+; Wa C3,CD5+; Waco3-CD5
DR   ArrayExpress; E-MTAB-4527
DR   DSMZ; ACC-769
DR   DSMZCellDive; ACC-769
DR   NCBI_Iran; C547
DR   Wikidata; Q54993504
RX   PubMed=8127151;
RX   PubMed=19358282;
RX   PubMed=23297799;
CC   Doubling time: ~40-50 hours (DSMZ=ACC-769).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-769; NCBI_Iran=C547
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9
ST   D16S539: 8,11 (NCBI_Iran=C547)
ST   D16S539: 9,12 (DSMZ=ACC-769)
ST   D18S51: 11,18 (NCBI_Iran=C547)
ST   D18S51: 12,20.2 (DSMZ=ACC-769)
ST   D19S433: 13,14
ST   D21S11: 29,30 (NCBI_Iran=C547)
ST   D21S11: 30,31 (DSMZ=ACC-769)
ST   D2S1338: 20,25
ST   D3S1358: 15,16 (NCBI_Iran=C547)
ST   D3S1358: 16,17 (DSMZ=ACC-769)
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 19,20 (NCBI_Iran=C547)
ST   FGA: 20,21 (DSMZ=ACC-769)
ST   Penta D: 11,12
ST   Penta E: 15,21
ST   TH01: 8,9 (NCBI_Iran=C547)
ST   TH01: 8,9.3 (DSMZ=ACC-769)
ST   TPOX: 7,11 (NCBI_Iran=C547)
ST   TPOX: 8,11 (DSMZ=ACC-769)
ST   vWA: 18
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y549 ! WA-OSEL
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 15
//
RX   PubMed=8127151;
RA   Wendel-Hansen V., Sallstrom J., de Campos-Lima P.O., Kjellstrom G.,
RA   Sandlund A., Siegbahn A., Carlsson M., Nilsson K., Rosen A.;
RT   "Epstein-Barr virus (EBV) can immortalize B-CLL cells activated by
RT   cytokines.";
RL   Leukemia 8:476-484(1994).
//
RX   PubMed=19358282; DOI=10.1002/ijc.24351;
RA   Inagaki A., Ishida T., Yano H., Ishii T., Kusumoto S., Ito A., Ri M.,
RA   Mori F., Ding J.-M., Komatsu H., Iida S., Ueda R.;
RT   "Expression of the ULBP ligands for NKG2D by B-NHL cells plays an
RT   important role in determining their susceptibility to
RT   rituximab-induced ADCC.";
RL   Int. J. Cancer 125:212-221(2009).
//
RX   PubMed=23297799; DOI=10.3109/10428194.2013.764418;
RA   Myhrinder A.L., Hellqvist E., Bergh A.-C., Jansson M.,
RA   Nilsson K., Hultman P., Jonasson J., Buhl A.M., Pedersen L.B.,
RA   Jurlander J., Klein E., Weit N., Herling M., Rosenquist R., Rosen A.;
RT   "Molecular characterization of neoplastic and normal 'sister'
RT   lymphoblastoid B-cell lines from chronic lymphocytic leukemia.";
RL   Leuk. Lymphoma 54:1769-1779(2013).
//